Substanzgebundene Abhängigkeitserkrankungen und bulimische Essstörungen

J. Höppner; P. M. Kreuzer; L. Wendler; C. Schönfeldt-Lecuona; P. Eichhammer; J.-P. Lefaucheur; B. Langguth

doi:10.1055/s-0038-1627656

Nervenheilkunde, Table of Contents

Nervenheilkunde 2015; 34(12): 998-1005
DOI: 10.1055/s-0038-1627656

Hirnstimulation

Schattauer GmbH

Substanzgebundene Abhängigkeitserkrankungen und bulimische Essstörungen

Therapeutischer Einsatz von rTMSRepetitive transcranial magnetic stimulation (rTMS) in substance misuse and bulimia

J. Höppner

¹Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsmedizin Rostock

,

P. M. Kreuzer

²Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum, Regensburg

,

L. Wendler

¹Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsmedizin Rostock

,

C. Schönfeldt-Lecuona

³Klinik für Psychiatrie and Psychotherapie III, Universitätsklinikum Ulm

,

P. Eichhammer

²Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum, Regensburg

,

J.-P. Lefaucheur

⁴Department of Physiology, Henri Mondor Hospital, Assistance Publique – Hôpitaux de Paris, Créteil, France

⁵EA 4391, Nerve Excitability and Therapeutic team, Faculty of Medicine, Paris Est Créteil University, Créteil, France

,

B. Langguth

²Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum, Regensburg

› Author Affiliations

Abstract

Zusammenfassung

Einleitung: Es soll ein Überblick über die Studienlage zur repetitiven transkraniellen Magnetstimulation (rTMS) bei substanzgebundene Abhängigkeiten und bulimischen Essstörungen gegeben werden. Material und Methoden: Anhand einer Pubmed-Recherche wurden Studien identifiziert, in denen rTMS zur Behandlung von substanzgebundener Abhängigkeit untersucht wurde. Diese Studien wurden hinsichtlich eingeschlossener Patienten, Stimulationsparameter und Ergebnissen ausgewertet. Darüber hinaus werden je nach Studienlage Empfehlungen zur Verwendung der rTMS bei den verschiedenen Abhängigkeiten gegeben. Ergebnisse: Die Pubmed-Recherche identifizierte 20 Publikationen zur Anwendung der rTMS, davon vier zur “deep” TMS, sieben Studien bei Alkoholabhängigkeit, acht bei Nikotinabhängigkeit, zwei bei Drogenabhängigkeit sowie drei Studien zur Behandlung bulimischer Essstörungen. Außerdem wurden zwölf Review-Artikel identifiziert. Es wurde meist hochfrequent stimuliert (HFrTMS). Zielort war überwiegend der dorsolaterale präfrontale Kortex (DLPFC), vor dem Hintergrund der neuropsychologischen Bedeutung dieser Region bei der Ausbildung von Craving und der Effekte auf die dopaminerge Neurotransmission. Die Ergebnisse der einzelnen Studien sind sehr heterogen und die Fallzahlen der verfügbaren Studien verhältnismäßig gering. Schlussfolgerungen: Nur für die Anwendung bei Nikotinabhängigkeit kann ein möglicher Effekt der HF-rTMS über dem linken DLPFC diskutiert werden. Aufgrund dieser Limitationen und kleinen Fallzahlen kann keine Empfehlung für eine rTMS-Behandlung von Alkohol- oder Drogenabhängigkeit und bulimischen Essstörungen gegeben werden. Die Vorarbeiten rechtfertigen aber weitere klinische Anwendungsstudien an größeren Fallzahlen.

Summary

Objectives: An overview about the current data concerning repetitive transcranial magnetic stimulation (rTMS) in substance use disorders (SUD) and bulimia should be given. Material and methods: Based on a pubmed search, rTMS studies in SUD were compared regarding included patients, stimulation parameters and results. Results: The pubmed search identified a total of 20 articles concerning the use of rTMS, including four manuscripts referring to deep TMS, seven to alcohol dependence, eight to nicotine dependence, two to drug dependence (cocain and metamphetamine) und three to bulimic eating disorders. In addition, twelve reviews were published. Most of the studies applied high frequency rTMS (HF-rTMS). The target region was the dorsolateral prefrontal cortex (DLPFC) in most of the cases, because of its neuropsychological role in craving and because of the well-known effects of DLPFC rTMS on dopaminergic neurotransmission. In summary the study results are very heterogenous and investigated samples are rather small. Conclusions: A possible therapeutic effect of HF-rTMS over the left DLPFC can only be discussed for nicotine dependence. In all other SUDs, rTMS can not be recommended because of methodological limitations. However, the preliminary data justify further clinical studies based on larger sample sizes.

Schlüsselwörter

Substanzabhängigkeit - Alkohol - Nikotin - Bulimie - rTMS

Keywords

Substance use disorders - alcohol - nicotine - bulimic eating disorders - rTMS

Full Text

References

Literatur
1 Fant RV, Buchhalter AR, Buchman AC, Henningfield JE. Pharmacotherapy for tobacco dependence. Handbook of experimental pharmacology 2009; 192: 487-510.
2 Heinz A, Beck A, Grusser SM, Grace AA, Wrase J. Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addiction biology 2009; 14 (01) 108-18.
3 Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. The American journal of psychiatry 2002; 159 (10) 1642-52.
4 Wilson SJ, Sayette MA, Fiez JA. Prefrontal responses to drug cues: a neurocognitive analysis. Nature neuroscience 2004; 07 (03) 211-4.
5 Potgieter AS, Deckers F, Geerlings P. Craving and relapse measurement in alcoholism. Alcohol and alcoholism (Oxford, Oxfordshire) 1999; 34 (02) 254-60.
6 Olbrich HM, Valerius G, Paris C, Hagenbuch F, Ebert D, Juengling FD. Brain activation during craving for alcohol measured by positron emission tomography. The Australian and New Zealand journal of psychiatry 2006; 40 (02) 171-8.
7 Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, Kahnt T. et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 2007; 35 (02) 787-94.
8 Lingford-Hughes AR, Daglish MR, Stevenson BJ, Feeney A, Pandit SA, Wilson SJ. et al. Imaging alcohol cue exposure in alcohol dependence using a PET 15O-H2O paradigm: results from a pilot study. Addiction biology 2006; 11 (01) 107-15.
9 George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP. et al. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Archives of general psychiatry 2001; 58 (04) 345-52.
10 Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser SM. et al. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. The American journal of psychiatry 2004; 161 (10) 1783-9.
11 Alba-Ferrara L, Fernandez F, Salas R, de Erausquin GA. Transcranial magnetic stimulation and deep brain stimulation in the treatment of alcohol dependence. Addictive disorders & their treatment 2014; 13 (04) 159-69.
12 Alba-Ferrara LM, Fernandez F, de Erausquin GA. The use of neuromodulation in the treatment of cocaine dependence. Addictive disorders & their treatment 2014; 13 (01) 1-7.
13 Barr MS, Farzan F, Wing VC, George TP, Fitzgerald PB, Daskalakis ZJ. Repetitive transcranial magnetic stimulation and drug addiction. International review of psychiatry (Abingdon, England) 2011; 23 (05) 454-66.
14 Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Current drug abuse reviews 2008; 01 (03) 328-39.
15 Bellamoli E, Manganotti P, Schwartz RP, Rimondo C, Gomma M, Serpelloni G. rTMS in the treatment of drug addiction: an update about human studies. Behavioural neurology 2014; 2014: 815215.
16 Bou RKhalil, El Hachem C. Potential role of repetitive transcranial magnetic stimulation in obesity. Eat Weight Disord 2014; 19 (03) 403-7.
17 Grall-Bronnec M, Sauvaget A. The use of repetitive transcranial magnetic stimulation for modulating craving and addictive behaviours: a critical literature review of efficacy, technical and methodological considerations. Neurosci Biobehav Rev 2014; 47: 592-613.
18 Herremans SC, Baeken C. The current perspective of neuromodulation techniques in the treatment of alcohol addiction: a systematic review. Psychiatria Danubina 2012; 24 Suppl 1 S14-20.
19 Herrold AA, Kletzel SL, Harton BC, Chambers RA, Jordan N, Pape TL. Transcranial magnetic stimulation: potential treatment for co-occurring alcohol, traumatic brain injury and posttraumatic stress disorders. Neural regeneration research 2014; 09 (19) 1712-30.
20 Jansen JM, Daams JG, Koeter MW, Veltman DJ, van den Brink W, Goudriaan AE. Effects of noninvasive neurostimulation on craving: a metaanalysis. Neurosci Biobehav Rev 2013; 37 (10) 2472-80.
21 Kravitz AV, Tomasi D, LeBlanc KH, Baler R, Volkow ND, Bonci A. et al. Cortico-striatal circuits: Novel therapeutic targets for substance use disorders. Brain research. 2015 dx.doi.org/10.1016/j.brainres.2015.03.048.
22 Wing VC, Barr MS, Wass CE, Lipsman N, Lozano AM, Daskalakis ZJ. et al. Brain stimulation methods to treat tobacco addiction. Brain stimulation 2013; 06 (03) 221-30.
23 Mishra BR, Nizamie SH, Das B, Praharaj SK. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction (Abingdon, England) 2010; 105 (01) 49-55.
24 Hoppner J, Broese T, Wendler L, Berger C, Thome J. Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence. World J Biol Psychiatry 2011; 12 Suppl 1 57-62.
25 Mishra BR, Praharaj SK, Katshu MZ, Sarkar S, Nizamie SH. Comparison of anticraving efficacy of right and left repetitive transcranial magnetic stimulation in alcohol dependence: a randomized double-blind study. The Journal of neuropsychiatry and clinical neurosciences 2015; 27 (01) e54-9.
26 Herremans SC, Baeken C, Vanderbruggen N, Vanderhasselt MA, Zeeuws D, Santermans L. et al. No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Drug and alcohol dependence 2012; 120 (1–3) 209-13.
27 Rapinesi C, Kotzalidis GD, Scatena P, Del Casale A, Janiri D, Callovini G. et al. Alcohol and suicidality: could deep transcranial magnetic stimulation (dTMS) be a possible treatment?. Psychiatria Danubina 2014; 26 (03) 281-4.
28 Girardi P, Rapinesi C, Chiarotti F, Kotzalidis GD, Piacentino D, Serata D. et al. Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment. World J Biol Psychiatry 2015; 16 (01) 66-73.
29 Rapinesi C, Curto M, Kotzalidis GD, Del Casale A, Serata D, Ferri VR. et al. Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): a 6-month, open label, follow-up study. Journal of affective disorders 2015; 174: 57-63.
30 Ceccanti M, Inghilleri M, Attilia ML, Raccah R, Fiore M, Zangen A. et al. Deep TMS on alcoholics: effects on cortisolemia and dopamine pathway modulation. A pilot study. Canadian journal of physiology and pharmacology 2015; 93 (04) 283-90.
31 Eichhammer P, Johann M, Kharraz A, Binder H, Pittrow D, Wodarz N. et al. High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. The Journal of clinical psychiatry 2003; 64 (08) 951-3.
32 Prikryl R, Ustohal L, Kucerova HP, Kasparek T, Jarkovsky J, Hublova V. et al. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients. Progress in neuro-psychopharmacology & biological psychiatry 2014; 49: 30-5.
33 Pripfl J, Tomova L, Riecansky I, Lamm C. Transcranial magnetic stimulation of the left dorsolateral prefrontal cortex decreases cue-induced nicotine craving and EEG delta power. Brain stimulation 2014; 07 (02) 226-33.
34 Rose JE, McClernon FJ, Froeliger B, Behm FM, Preud’homme X, Krystal AD. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biological psychiatry 2011; 70 (08) 794-9.
35 Dinur-Klein L, Dannon P, Hadar A, Rosenberg O, Roth Y, Kotler M. et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biological psychiatry 2014; 76 (09) 742-9.
36 Camprodon JA, Martinez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug and alcohol dependence 2007; 86 (01) 91-4.
37 Li X, Malcolm RJ, Huebner K, Hanlon CA, Taylor JJ, Brady KT. et al. Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study. Drug and alcohol dependence 2013; 133 (02) 641-6.
38 Uher R, Murphy T, Brammer MJ, Dalgleish T, Phillips ML, Ng VW. et al. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. The American journal of psychiatry 2004; 161 (07) 1238-46.
39 Van den Eynde F, Claudino AM, Mogg A, Horrell L, Stahl D, Ribeiro W. et al. Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biological psychiatry 2010; 67 (08) 793-5.
40 Barth KS, Rydin-Gray S, Kose S, Borckardt JJ, O’Neil PM, Shaw D. et al. Food cravings and the effects of left prefrontal repetitive transcranial magnetic stimulation using an improved sham condition. Frontiers in Psychiatry 2011; 02: 9.
41 Claudino AM, Van den Eynde F, Stahl D, Dew T, Andiappan M, Kalthoff J. et al. Repetitive transcranial magnetic stimulation reduces cortisol concentrations in bulimic disorders. Psychological Medicine 2011; 41 (06) 1329-36.
42 Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 2007; 64 (11) 1575-9.
43 Smolka MN, Budde H, Karow AC, Schmidt LG. Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence. Psychopharmacology (Berl) 2004; 175 (03) 374-81.
44 Wang GJ, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004; 23 (03) 39-53.
45 Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res Brain Res Rev 1998; 28 (03) 309-69.
46 Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21 (15) RC157.
47 Fisher DJ, Daniels R, Jaworska N, Knobelsdorf A, Knott VJ. Effects of acute nicotine administration on resting EEG in nonsmokers. Exp Clin Psychopharmacol 2012; 20 (01) 71-5.
48 Knyazev GG. EEG delta oscillations as a correlate of basic homeostatic and motivational processes. Neurosci Biobehav Rev 2012; 36 (01) 677-95.
49 Griskova I, Ruksenas O, Dapsys K, Herpertz S, Hoppner J. The effects of 10 Hz repetitive transcranial magnetic stimulation on resting EEG power spectrum in healthy subjects. Neurosci Lett 2007; 419 (02) 162-7.
50 Okamura H, Jing H, Takigawa M. EEG modification induced by repetitive transcranial magnetic stimulation. J Clin Neurophysiol 2001; 18 (04) 318-25.
51 De Ridder D, Vanneste S, Kovacs S, Sunaert S, Dom G. Transient alcohol craving suppression by rTMS of dorsal anterior cingulate: an fMRI and LORETA EEG study. Neurosci Lett 2011; 496 (01) 5-10.
52 Rushworth MF, Behrens TE. Choice, uncertainty and value in prefrontal and cingulate cortex. Nature neuroscience 2008; 11 (04) 389-97.
53 Krain AL, Wilson AM, Arbuckle R, Castellanos FX, Milham MP. Distinct neural mechanisms of risk and ambiguity: a meta-analysis of decisionmaking. Neuroimage 2006; 32 (01) 477-84.
54 Knoch D, Gianotti LR, Pascual-Leone A, Treyer V, Regard M, Hohmann M. et al. Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risktaking behavior. J Neurosci 2006; 26 (24) 6469-72.
55 Fecteau S, Fregni F, Boggio PS, Camprodon JA, Pascual-Leone A. Neuromodulation of decisionmaking in the addictive brain. Subst Use Misuse 2010; 45 (11) 1766-86.
56 Elliott R, Deakin B. Role of the orbitofrontal cortex in reinforcement processing and inhibitory control: evidence from functional magnetic resonance imaging studies in healthy human subjects. Int Rev Neurobiol 2005; 65: 89-116.
57 Fowler JS, Volkow ND. PET imaging studies in drug abuse. J Toxicol Clin Toxicol 1998; 36 (03) 163-74.
58 Ernst M, Paulus MP. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biological psychiatry 2005; 58 (08) 597-604.